Adverum Biotechnologies Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Adverum Biotechnologies, Inc. |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financials, SEC filing
Related Tickers: ADVM
TL;DR
**Adverum Biotechnologies (ADVM) filed its Q1 2025 10-Q. Check financials.**
AI Summary
Adverum Biotechnologies, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and disclosures relevant to investors are presented.
Why It Matters
This filing provides investors with the latest financial health and operational status of Adverum Biotechnologies, Inc. as of March 31, 2025.
Risk Assessment
Risk Level: medium — As a biotechnology company, Adverum faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — End of Reporting Period (Covers financial data up to this date for Q1 2025.)
- 2025-05-14 — Filing Date (Date the 10-Q was officially submitted to the SEC.)
- 2024-12-31 — Prior Year End (Provides a comparison point for financial data.)
Key Players & Entities
- Adverum Biotechnologies, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250514 (date) — Filing date
- 001-36579 (company) — SEC file number
- Avalanche Biotechnologies, Inc. (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
What was Adverum Biotechnologies, Inc.'s former company name?
Adverum Biotechnologies, Inc.'s former company name was Avalanche Biotechnologies, Inc.
What is the SEC file number for Adverum Biotechnologies, Inc.?
The SEC file number for Adverum Biotechnologies, Inc. is 001-36579.
What is the fiscal year end for Adverum Biotechnologies, Inc.?
The fiscal year end for Adverum Biotechnologies, Inc. is December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Adverum Biotechnologies, Inc..